Author: Bluejay Diagnostics, Inc.

Posted Date:

April 7, 2026

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Bluejay Diagnostics, Inc.

April 7, 2026
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Bluejay Diagnostics, Inc.

March 12, 2026
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook

Bluejay Diagnostics, Inc.

March 6, 2026
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Bluejay Diagnostics, Inc.

February 20, 2026
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Bluejay Diagnostics, Inc.

February 17, 2026
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

Bluejay Diagnostics, Inc.

January 28, 2026